Article
05 Nov 2025
Streamlining The Studies: New FDA Guidance Aims To Speed Up Biosimilar Development
AUTHORS CONTENT
Article
31 Jul 2024
FDA Expands Practice Of Permitting Population-Based Skinny Label "Carve-Ins"
Article
30 Apr 2024
Re-Evaluating Trade Secret Policies After FTC Adopts Rule Banning Non-Compete Agreements
Article
17 Apr 2024
A Rare Bird? TriZetto Collects $14.5M In Attorneys' Fees But No Trade Secret Damages
Article
11 Mar 2024
Over-Sweetening The Pot? When Selling A Product Bars Patenting The Manufacturing Process Under The AIA
Article
19 Jan 2024
Recognizing Risk: When Pursuing A Competitive Edge Creates Exposure To Trade Secret Claims
Article
01 Dec 2023
Motorola v. Hytera: Seventh Circuit Set To Hear Arguments On The Extraterritorial Reach Of DTSA
Article
23 Nov 2023
Trade Secrets, ET, And The ITC
Article
14 Nov 2023
A Mirage Or An Oasis? Avoided R&D Costs Under The DTSA
Article
09 Nov 2023
Failing The Litmus Test? Weighing The Extrinsic Evidence In Construing "A pH Of 13 Or Higher"
Article
06 Nov 2023
Appian Reimagines The High-Low To Preserve $500M-$2B In Trade Secret Damages
Article
27 Oct 2023
The Five Eyes Stare Down Trade Secret Theft (Video)
Article
08 Sep 2023
District Of Delaware Magistrate Judge Recommends Dismissal Of Claims Of Induced Infringement In Skinny Label Case
Article
06 Sep 2023
Federal Circuit Applies Lead Compound Analysis And Confirms Obviousness Of Deuterated Derivatives Of Ruxolitinib